grant

Developing and quantitatively optimising a Just-In-Time-Adaptive-Intervention (JITAI) to improve adherence to medication in women with breast cancer.

Organization UKRILocation United Kingdom
UKRIUK ResearchGrantActive
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Breast cancer is the most common cancer in the UK and second most common cause of cancer death (ONS, 2019). Adjuvant hormonal therapy is an established treatment which reduces recurrence in women with breast cancer (EBCTCG, 2005) but up to 75% of women do not adhere to these therapies (Murphy et al., 2012), increasing their mortality risk…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Developing and quantitatively optimising a Just-In-Time-Adaptive-Intervention (JITAI) to improve adherence to medication | Dev Procure